# THAR PHARMACEUTICALS INC: Form D filings

THAR PHARMACEUTICALS INC, a pharmaceuticals company in Pittsburgh, PA, filed 10 Form D notices with the SEC between 2009 and 2016. The latest, on April 5, 2016, reports $1.4 million sold of a $3 million offering to 18 investors.

Find out what THAR PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20THAR%20PHARMACEUTICALS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=THAR%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fthar-pharmaceuticals-inc-1428369)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20THAR%20PHARMACEUTICALS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=THAR%20PHARMACEUTICALS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fthar-pharmaceuticals-inc-1428369)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania): 987 rows, by operating companies, filed since November 1, 2024, $49.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/pennsylvania
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 150 GAMMA DRIVE, Pittsburgh, PA, 15238
- Phone: (412) 968-0200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1428369

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 5, 2016 | Amendment | $3,000,000 | $1,371,500 | $1,628,500 | 18 | Aug 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836916000001/0001428369-16-000001-index.htm) |
| Sep 2, 2014 | New notice | $3,000,000 | $115,000 | $2,885,000 | 2 | Aug 19, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836914000003/0001428369-14-000003-index.htm) |
| Nov 12, 2013 | Amendment | $5,000,000 | $3,940,000 | $1,060,000 | 32 | Nov 14, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836913000002/0001428369-13-000002-index.htm) |
| Apr 19, 2013 | Amendment | $5,000,000 | $1,950,000 | $3,050,000 | 21 | Oct 26, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836913000001/0001428369-13-000001-index.htm) |
| Nov 30, 2012 | New notice | $2,000,000 | $405,000 | $1,595,000 | 6 | Oct 26, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836912000002/0001428369-12-000002-index.htm) |
| Jul 3, 2012 | Amendment | $2,500,000 | $325,000 | $2,175,000 | 3 | Oct 26, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836912000001/0001428369-12-000001-index.htm) |
| Nov 18, 2011 | New notice | $1,000,000 | $250,000 | $750,000 | 1 | Oct 26, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836911000002/0001428369-11-000002-index.htm) |
| Jan 3, 2011 | Amendment | $9,636,000 | $4,311,656 | $5,324,344 | 5 | Nov 29, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836911000001/0001428369-11-000001-index.htm) |
| Dec 8, 2010 | New notice | $8,092,792 | $2,025,000 | $6,067,792 | 5 | Nov 29, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836910000002/0001428369-10-000002-index.htm) |
| Dec 21, 2009 | Amendment | $1,500,000 | $1,242,000 | $258,000 | 6 | Jan 7, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1428369/000142836909000002/0001428369-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Raymond K. Houck | Executive Officer, Director |  |
| Lalit K. Chordia | Director |  |
| Mazen K. Hanna | Executive Officer |  |
| Ira K. Kalfus | Executive Officer |  |
| Philip K. Sussman | Director |  |
| Robert K. Roy | Director |  |
| Jason K. Bablak | Executive Officer |  |
| Brian K. Moyer | Executive Officer |  |

## Other pharmaceuticals companies in Pennsylvania that filed recently

- [Telemachus Therapeutics, Inc.](https://specstream.ai/data/form-d/company/telemachus-therapeutics-inc-2152986) $375,000 · Oct 28, 2026
- [EpiVario Inc.](https://specstream.ai/data/form-d/company/epivario-inc-1753351) $185,000 · Oct 13, 2026
- [Maxona Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/maxona-pharmaceuticals-inc-1857448) $5.8 million · Aug 14, 2026

[Every Form D from the week of Apr 4, 2016](https://specstream.ai/data/form-d/week/2016-04-04) · [All recent filings in Pennsylvania](https://specstream.ai/data/form-d/state/pennsylvania) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what THAR PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).